Aurobindo Perampanel approval could significantly impact the stock market, with a $67 million valuation at stake.
Month: October 2026
Severe Hypertriglyceridemia Market: Is It the Best Growth Opportunity?
Severe Hypertriglyceridemia Market is poised for growth with new therapies. Discover the potential impact of Ionis’ TRYNGOLZA and more.
Trade Margins on Anti-Cancer Drugs: Clear Price Drop Ahead
Trade margins on anti-cancer drugs are capped at 30%, leading to potential price drops of up to 70%.
Essential Patent Filing Insights: Avoid Delays and Strengthen Your Application
Explore essential insights for patent application to avoid delays and strengthen your submission.
Drug Price Controls: The Right Way to Lower Costs
Drug price controls are essential for making medications affordable for all.
Cancer medicine price controls: Smart Proven Savings Ahead
Cancer medicine price controls are set to save patients ₹2,500 crore annually as drug prices may fall up to 70%.
Aurobindo Pharma shares: Best Proven Growth Potential
Aurobindo Pharma shares are in focus after USFDA approval for Perampanel, signaling promising growth in the pharmaceutical sector.